Overview
Hironobu Ohmatsu practices practicing medicine in Kashiwa, Japan.
Ohmatsu is highly rated in 7 conditions, according to our data. Their clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Familial Atypical Multiple Mole Melanoma Syndrome.
They are actively involved in clinical research, co-authoring 44 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hironobu Ohmatsu
Is Hironobu Ohmatsu a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Hironobu Ohmatsu is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hironobu Ohmatsu participate in research or clinical trials?
Yes. Hironobu Ohmatsu has published 44 articles and abstracts on conditions like Lung Cancer. You can view a list of Hironobu Ohmatsu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerOhmatsu isDistinguished. Learn about Lung Cancer.
- Advanced
- Cutaneous T-Cell Lymphoma (CTCL)
- EGFR Positive Lung CancerOhmatsu isAdvanced. Learn about EGFR Positive Lung Cancer.
- Familial Atypical Multiple Mole Melanoma Syndrome
- Lung AdenocarcinomaOhmatsu isAdvanced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)
- Experienced
- AgranulocytosisOhmatsu isExperienced. Learn about Agranulocytosis.
- Atopic DermatitisOhmatsu isExperienced. Learn about Atopic Dermatitis.
- EmphysemaOhmatsu isExperienced. Learn about Emphysema.
- Non-Hodgkin LymphomaOhmatsu isExperienced. Learn about Non-Hodgkin Lymphoma.
- PIK3CA-Related Overgrowth Spectrum
- Squamous Cell Lung CarcinomaOhmatsu isExperienced. Learn about Squamous Cell Lung Carcinoma.
- T-Cell LymphomaOhmatsu isExperienced. Learn about T-Cell Lymphoma.
- Thymic Epithelial TumorOhmatsu isExperienced. Learn about Thymic Epithelial Tumor.